SILENCE THERAPEUTICS PLC's ticker is SLN and the CUSIP is 82686Q101. A total of 3 filers reported holding SILENCE THERAPEUTICS PLC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $523,376 | +45.0% | 53,297 | -18.8% | 0.00% | – |
Q2 2023 | $360,834 | -19.9% | 65,606 | -9.7% | 0.00% | – |
Q1 2023 | $450,597 | -86.0% | 72,677 | -65.6% | 0.00% | – |
Q4 2022 | $3,217,339 | +106.6% | 210,973 | +36.0% | 0.00% | – |
Q3 2022 | $1,557,000 | -14.3% | 155,159 | +1.2% | 0.00% | – |
Q2 2022 | $1,817,000 | -37.0% | 153,293 | +1.1% | 0.00% | – |
Q1 2022 | $2,882,000 | -27.7% | 151,666 | -9.1% | 0.00% | – |
Q4 2021 | $3,986,000 | +1728.4% | 166,854 | +1471.9% | 0.00% | – |
Q3 2021 | $218,000 | -12.8% | 10,615 | +11.0% | 0.00% | – |
Q2 2021 | $250,000 | +7.3% | 9,565 | -5.5% | 0.00% | – |
Q1 2021 | $233,000 | +429.5% | 10,118 | +405.9% | 0.00% | – |
Q4 2020 | $44,000 | +37.5% | 2,000 | 0.0% | 0.00% | – |
Q3 2020 | $32,000 | – | 2,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 1,312,233 | $12,886,128 | 11.68% |
M28 Capital Management LP | 363,800 | $3,572,516 | 4.10% |
TCG Crossover Management, LLC | 2,104,875 | $20,669,873 | 3.04% |
Lombard Odier Asset Management (Europe) Ltd | 3,443,912 | $33,819,216 | 1.73% |
Lynx1 Capital Management LP | 235,787 | $2,315,428 | 1.53% |
Artal Group S.A. | 2,500,000 | $24,550 | 1.05% |
Lombard Odier Asset Management (USA) Corp | 4,057,932 | $33,740,000 | 0.76% |
Deep Track Capital, LP | 1,951,580 | $19,164,516 | 0.74% |
Frazier Life Sciences Management, L.P. | 881,173 | $8,661,931 | 0.58% |
BVF INC/IL | 1,508,416 | $14,827,729 | 0.40% |